AERIE PHARMACEUTICALS INC - COM (AERI)

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
32,439,327
Share change
+4,634,141
Total reported value
$1,224,263,296
Put/Call ratio
70%
Price per share
$37.74
Number of holders
161
Value change
+$176,293,073
Number of buys
109
Number of sells
38

Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q3 2016

As of 30 Sep 2016, AERIE PHARMACEUTICALS INC - COM (AERI) was held by 161 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,439,327 shares. The largest 10 holders included JENNISON ASSOCIATES LLC, WELLINGTON MANAGEMENT GROUP LLP, Partner Fund Management, L.P., Foresite Capital Management III, LLC, Foresite Capital Management II, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., DEERFIELD MANAGEMENT CO, TPG Group Holdings (SBS) Advisors, Inc., VANGUARD GROUP INC, and BlackRock Fund Advisors. This page lists 161 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.